These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Biological therapies directed against cells in autoimmune disease. Hasler P Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955 [TBL] [Abstract][Full Text] [Related]
44. [Advances and failures in rheumatology during the past 3 decades]. Châtel A Orv Hetil; 1976 Oct; 117(40):2427-9. PubMed ID: 787885 [No Abstract] [Full Text] [Related]
47. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? Jorgensen C; Apparailly F; Sany J Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909 [No Abstract] [Full Text] [Related]
48. Mechanisms of autoimmunity in human diseases: a critical review of current dogma. Benson RA; Brewer JM; Platt AM Curr Opin Rheumatol; 2014 Mar; 26(2):197-203. PubMed ID: 24445477 [TBL] [Abstract][Full Text] [Related]
49. T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis. Bridges SL; Moreland LW Rheum Dis Clin North Am; 1998 Aug; 24(3):641-50. PubMed ID: 9710892 [TBL] [Abstract][Full Text] [Related]
50. Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides. Mouzaki A; Deraos S; Chatzantoni K Curr Med Chem; 2005; 12(13):1537-50. PubMed ID: 15974986 [TBL] [Abstract][Full Text] [Related]
52. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Waldmann T Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S161-7. PubMed ID: 12110135 [TBL] [Abstract][Full Text] [Related]
53. B cells as a therapeutic target in autoimmune disease. Goronzy JJ; Weyand CM Arthritis Res Ther; 2003; 5(3):131-5. PubMed ID: 12723978 [TBL] [Abstract][Full Text] [Related]
54. Clinical and preclinical studies presented at the Keystone Symposium on Arthritis, Related Diseases, and Cytokines. Ralph P Lymphokine Cytokine Res; 1993 Aug; 12(4):261-3. PubMed ID: 8218599 [TBL] [Abstract][Full Text] [Related]
55. T-cell receptors and rheumatic disease: approaches to repertoire analysis. Bowness P; Bell J Br J Rheumatol; 1992 Jan; 31(1):3-8. PubMed ID: 1730102 [TBL] [Abstract][Full Text] [Related]
56. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. Tran TH; Mattheolabakis G; Aldawsari H; Amiji M Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185 [TBL] [Abstract][Full Text] [Related]
58. [Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"]. Mei H; Dörner T Z Rheumatol; 2009 Jul; 68(5):364-9. PubMed ID: 19513730 [TBL] [Abstract][Full Text] [Related]